Skip to main content
SpringerLink
Log in

The placebo phenomenon and the underlying mechanisms

  • Review Article
  • Published:
Hormones Aims and scope Submit manuscript

Abstract

The clinical role of the placebo effect is a topic of increasing interest for the scientific community. Focus is shifting from the inert role of placebos in randomized controlled trials (RCTs) to potential effects in clinical applications, since the phenomenon is thought to be inherent in routine clinical practice, affecting therapy success rates. Mediation of the mind-brain-body relationship involves both psychosocial and neurobiological factors, the interaction of which comprises the placebo mechanisms. Psychosocial factors include environmentally induced expectations, reward expectations, and even conditioned responses to certain stimuli. Expectations also depend on previous experience of the patient with a similar procedure and can affect future responses. Moreover, the supportive bedside behavior of the clinician and the positive framing of information provided to the patient have proven to be of great importance, setting the foundations for reconsideration of standardized practices. Neurobiological mechanisms mediate these effects through neurotransmitter and neuromodulator pathways. The best understood mechanisms are those regulating non-opioid- and opioid-mediated analgesic responses that implicate specific brain regions of pain control and activation of endogenous opioids. Other responses concern, among others, hormonal control, motor performance, and antidepressant responses. Although mechanisms underlying placebo responses are not as yet completely elucidated, there is substantial evidence suggesting that placebo effects are indicative of healthy functioning of intact brain structures and occur through actual functional changes, and are not simply subjective symptom reports. These effects can be utilized in treatment optimization while maintaining an ethical and respectful manner toward the patient and the standardized disclosure procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Price DD, Finniss DG, Benedetti F (2008) A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol 59:565–590

    Article  PubMed  Google Scholar 

  2. Carlino E, Piedimonte A, Benedetti F (2016) Nature of the placebo and nocebo effect in relation to functional neurologic disorders. Handb Clin Neurol 139:597–606

    Article  CAS  PubMed  Google Scholar 

  3. Colloca L, Benedetti F (2005) Placebos and painkillers: is mind as real as matter? Nat Rev Neurosci 6:545–552

    Article  CAS  PubMed  Google Scholar 

  4. Vase L, Riley JL III, Price DD (2002) A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 99:443–452

    Article  PubMed  Google Scholar 

  5. Hróbjartsson A, Gøtzsche PC (2001) Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. New Engl J Med 344:1594–1602

    Article  PubMed  Google Scholar 

  6. Ito K, Corrigan B, Romero K, Anziano R, Neville J, Stephenson D et al (2013) Understanding placebo responses in Alzheimer’s disease clinical trials from the literature meta-data and CAMD database. J Alzheimers Dis 37:173–183

    Article  PubMed  Google Scholar 

  7. Ongaro G, Kaptchuk TJ (2019) Symptom perception, placebo effects, and the Bayesian brain. Pain 160:1–4

    Article  PubMed  Google Scholar 

  8. Schmid J, Theysohn N, Gass F, Benson S, Gramsch C, Forsting et al (2013) Neural mechanisms mediating positive and negative treatment expectations in visceral pain: a functional magnetic resonance imaging study on placebo and nocebo effects in healthy volunteers. Pain 154:2372–2380

  9. Carlino E, Benedetti F (2016) Different contexts, different pains, different experiences. Neurosci 338:19–26

    Article  CAS  Google Scholar 

  10. Amanzio M, Pollo A, Maggi G, Benedetti F (2001) Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain 90:205–215

    Article  CAS  PubMed  Google Scholar 

  11. Bingel U, Wanigasekera V, Wiech K, Mhuircheartaigh RN, Lee MC, Ploner M et al (2011) The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med 3:70

    Article  CAS  Google Scholar 

  12. Pollo A, Torre E, Lopiano L, Rizzone M, Lanotte M, Cavanna A et al (2002) Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. Neuroreport 13:1383–1386

    Article  PubMed  Google Scholar 

  13. Carlino E, Piedimonte A, Romagnolo A, Guerra G, Frisaldi E, Vighettia S et al (2019) Verbal communication about drug dosage balances drug reduction in Parkinson’s disease: behavioral and electrophysiological evidences. Parkinsonism Relat Disord 65:184–189

    Article  PubMed  Google Scholar 

  14. Kaptchuk TJ, Kelley JM, Conboy LA, Davis RB, Kerr CE, Jacobson E et al (2008) Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 336:999–1003

    Article  PubMed  PubMed Central  Google Scholar 

  15. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F (2010) Biological, clinical and ethical advances of placebo effects. Lancet 375:686–695

    Article  PubMed  PubMed Central  Google Scholar 

  16. Rief W, Glombiewski JA, Gollwitzer M, Schubö A, Schwarting R, Thorwart A (2015) Expectancies as core features of mental disorders. Curr Opin Psychiatry 28:378–385

    Article  PubMed  Google Scholar 

  17. Lidstone SC, Schulzer M, Dinelle K, Mak E, Sossi V, Ruth TJ et al (2010) Effects of expectation on placebo-induced dopamine release in Parkinson disease. Arch Gen Psychiatry 67:857–865

    Article  CAS  PubMed  Google Scholar 

  18. Setlow B, Schoenbaum G, Gallagher M (2003) Neural encoding in ventral striatum during olfactory discrimination learning. Neuron 38:625–636

    Article  CAS  PubMed  Google Scholar 

  19. Tobler PN, Fiorillo CD, Schultz W (2005) Adaptive coding of reward value by dopamine neurons. Science 307:1642–1645

    Article  CAS  PubMed  Google Scholar 

  20. Schultz W (2006) Behavioral theories and the neurophysiology of reward. Annu Rev Psychol 57:87–115

    Article  PubMed  Google Scholar 

  21. De la Fuente-Fernández R, Ruth TJ, Sossi V, Schulzer M, Calne DB, Stoessl AJ et al (2002) Expectation and dopamine release: mechanism of the placebo effect in Parkinson’s disease. Science 293:1164–1166

    Article  Google Scholar 

  22. Goetz CG, Laska E, Hicking C, Damier P, Mueller T, Nutt J et al (2008) Placebo influences on dyskinesia in Parkinson’s disease. Mov Disord 23:700–707

    Article  PubMed  PubMed Central  Google Scholar 

  23. Espay AJ, Norris MM, Eliassen JC, Dwivedi A, Smith MS, Banks C et al (2015) Placebo effect of medication cost in Parkinson disease: a randomized double-blind study. Neurology 84:794–802

    Article  PubMed  PubMed Central  Google Scholar 

  24. Olanow CW, Fahn S, Muenter M, Klawans H, Hurtig H, Stern M et al (1994) A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to sinemet® in Parkinson’s disease. Mov Disord 9:40–47

    Article  CAS  PubMed  Google Scholar 

  25. Barker Bausell R, Lao L, Bergman S, Lee WL, Berman BM (2005) Is acupuncture analgesia an expectancy effect? Preliminary evidence based on participants’ perceived assignments in two placebo-controlled trials. Eval Health Prof 28:9–26

    Article  PubMed  Google Scholar 

  26. Linde K, Witt C, Streng A, Weidenhammer W, Wagenpfeil S, Brinkhaus B et al (2007) The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain 128:264–271

    Article  PubMed  Google Scholar 

  27. Amanzio M, Benedetti F (1999) Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci 19:484–494

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Colloca L, Grillon C (2014) Understanding placebo and nocebo responses for pain management. Curr Pain Headache Rep 18:419

    Article  PubMed  PubMed Central  Google Scholar 

  29. Klinger R, Kothe R, Schmitz J, Kamping S, Flor H (2017) Placebo effects of a sham opioid solution: a randomized controlled study in patients with chronic low back pain. Pain 158:1893–1902

    Article  PubMed  Google Scholar 

  30. Benedetti F (2013) Placebo and the new physiology of the doctor-patient relationship. Physiol Rev 93:1207–1246

    Article  PubMed  PubMed Central  Google Scholar 

  31. Berna C, Kirsch I, Zion SR, Lee YC, Jensen KB, Sadler P et al (2017) Side effects can enhance treatment response through expectancy effects: an experimental analgesic randomized controlled trial. Pain 158:1014–1020

    Article  PubMed  PubMed Central  Google Scholar 

  32. Rief W, Glombiewski JA (2012) The hidden effects of blinded, placebo-controlled randomized trials: an experimental investigation. Pain 153:2473–2477

    Article  PubMed  Google Scholar 

  33. De Craen AJM, Roos PJ, De Vries AL, Kleijnen J (1996) Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness. BMJ 313:1624–1626

    Article  PubMed  PubMed Central  Google Scholar 

  34. Hadamitzky M, Lückemann L, Pacheco-López G, Schedlowski M (2020) Pavlovian conditioning of immunological and neuroendocrine functions. Physiol Rev 100:357–405

    Article  CAS  PubMed  Google Scholar 

  35. Pacheco-López G, Riether C, Doenlen R, Engler H, Niemi MB, Engler A et al (2009) Calcineurin inhibition in splenocytes induced by pavlovian conditioning. FASEB J 23:1161–1167

    Article  PubMed  CAS  Google Scholar 

  36. Ader R, Cohen N (1975) Behaviorally conditioned immunosuppression. Psychosom Med 37:333–340

    Article  CAS  PubMed  Google Scholar 

  37. Pacheco-López G, Engler H, Niemi MB, Schedlowski M (2006) Expectations and associations that heal: immunomodulatory placebo effects and its neurobiology. Brain Behav Immun 20:430–446

    Article  PubMed  Google Scholar 

  38. Khan KJ, Dubinsky MC, Ford AC, Ullman TA, Taley NJ, Moayyedi P (2011) Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 106:630–642

    Article  CAS  PubMed  Google Scholar 

  39. Theodosis-Nobelos P, Asimakopoulou E, Kokkinos S, Skavatsos D, Triantis C (2020) The placebo effect in pain management. Pharmakeftiki 32:78–93

    Google Scholar 

  40. Goebel MU, Trebst AE, Steiner J, Xie YF, Exton MS, Frede S et al (2002) Behavioral conditioning of immunosuppression is possible in humans. FASEB J 16:1869–1873

    Article  CAS  PubMed  Google Scholar 

  41. Goebel MU, Meykadeh N, Kou W, Schedlowski M, Hengge UR (2008) Behavioral conditioning of antihistamine effects in patients with allergic rhinitis. Psychother Psychosom 77:227–234

    Article  PubMed  Google Scholar 

  42. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I (2003) Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci 23:4315–4323

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Marshall GD (2004) Neuroendocrine mechanisms of immune dysregulation: applications to allergy and asthma. Ann Allergy Asthma Immunol 93:11–17

    Article  Google Scholar 

  44. Langewitz W, Izakovic J, Wyler J, Schindler C, Kiss A, Bircher AJ (2005) Effect of self-hypnosis on hay fever symptoms - a randomised controlled intervention study. Psychother Psychosom 74:165–172

    Article  PubMed  Google Scholar 

  45. Kirchhof J, Petrakova L, Brinkhoff A, Benson S, Schmidt J, Unteroberdörster M et al (2018) Learned immunosuppressive placebo responses in renal transplant patients. Proc Natl Acad Sci U S A 115:4223–4227

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Haour F (2005) Mechanisms of the placebo effect and of conditioning. NeuroImmunoModulation 12:195–200

    Article  CAS  PubMed  Google Scholar 

  47. Frisaldi E, Carlino E, Zibetti M, Barbiani D, Dematteis F, Lanotte M et al (2017) The placebo effect on bradykinesia in Parkinson’s disease with and without prior drug conditioning. Mov Disord 32:1474–1478

    Article  PubMed  Google Scholar 

  48. Carlino E, Piedimonte A, Frisaldi E (2014) The effects of placebos and nocebos on physical performance. Handb Exp Pharmacol 225:149–157

    Article  PubMed  Google Scholar 

  49. Carlino E, Benedetti F, Pollo A (2014) The effects of manipulating verbal suggestions on physical performance Z Psychol 222:154–164

  50. Carlino E, Guerra G, Piedimonte A (2016) Placebo effects: from pain to motor performance. Neurosci Lett 632:224–230

    Article  CAS  PubMed  Google Scholar 

  51. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J et al (2009) Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 63:533–543

    Article  CAS  PubMed  Google Scholar 

  52. Levine JD, Gordon NC, Fields HL (1978) The mechanism of placebo analgesia. Lancet 312:654–657

    Article  Google Scholar 

  53. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ et al (2004) Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 303:1162–1167

    Article  CAS  PubMed  Google Scholar 

  54. Benedetti F (1999) Inducing placebo respiratory depressant responses in humans via opioid receptors. Eur J Neurosci 11:625–631

    Article  CAS  PubMed  Google Scholar 

  55. Benedetti F, Lanotte M, Colloca L, Ducati A, Zibetti M, Lopiano L (2009) Electrophysiological properties of thalamic, subthalamic and nigral neurons during the anti-parkinsonian placebo response. J Physiol 587:3869–3883

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Chen X, Zhang J, Wang X (2016) Hormones in pain modulation and their clinical implications for pain control: a critical review. Hormones 15:313–320

    Article  PubMed  Google Scholar 

  57. Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK (2005) Neurobiological mechanisms of the placebo effect. J Neurosci 25:10390–10402

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Asimakopoulou E, Theodosis-Nobelos P, Triantis C (2018) Pain assessment and management in intensive care unit: pharmacological and non-pharmacological approaches. Hell J Nurs 57:349–336

    Google Scholar 

  59. Benedetti F, Amanzio M, Casadio C, Oliaro A, Maggi G (1997) Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain 71:135–140

    Article  CAS  PubMed  Google Scholar 

  60. Noble F, Wank SA, Crawley JN, Bradwejn J, Seroogy KB, Hamon M et al (1999) International union of pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol Rev 51:745–781

    CAS  PubMed  Google Scholar 

  61. Timothy Walsh B, Seidman SN, Sysko R, Gould M (2002) Placebo response in studies of major depression: variable, substantial, and growing. JAMA 287:1840–1847

    Article  PubMed  Google Scholar 

  62. Mayberg HS, Silva A, Brannan SK, Tekell JL, Mahurin RK, McGinnis S et al (2002) The functional neuroanatomy of the placebo effect. Am J Psychiatry 159:728–737

    Article  PubMed  Google Scholar 

  63. Ikemoto S, Panksepp J (1999) The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Rev 31:6–4

    Article  CAS  PubMed  Google Scholar 

  64. Schultz W (2000) Multiple reward signals in the brain. Nat Rev Neurosci 1:199–207

    Article  CAS  PubMed  Google Scholar 

  65. Knutson B, Cooper JC (2005) Functional magnetic resonance imaging of reward prediction. Curr Opin Neurol 18:411–417

    Article  PubMed  Google Scholar 

  66. Dursun E, Gezen-Ak D (2019) Vitamin D basis of Alzheimer’s disease: from genetics to biomarkers. Hormones 18:7–15

    Article  PubMed  Google Scholar 

  67. Benedetti F, Arduino C, Costa S, Vigghetti S, Tarenzi L, Rainero I et al (2006) Loss of expectation-related mechanisms in Alzheimer’s disease makes analgesic therapies less effective. Pain 121:133–144

    Article  CAS  PubMed  Google Scholar 

  68. Hall KT, Lembo AJ, Kirsch I, Ziogas DC, Douaiher JKB et al (2012) Catechol-O-methyltransferase val158met polymorphism predicts placebo effect in irritable bowel syndrome. PLoS One 7:e48135

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Hotamisligil GS, Breakefield XO (1991) Human monoamine oxidase a gene determines levels of enzyme activity. Am J Hum Genet 49:383–392

    CAS  PubMed  PubMed Central  Google Scholar 

  70. Furmark T, Appel L, Henningsson S, Åhs F, Faria V, Linnman C et al (2008) A link between serotonin-related gene polymorphisms, amygdala activity, and placebo-induced relief from social anxiety. J Neurosci 28:13066–13074

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Benedetti F, Amanzio M, Rosato R, Blanchard C (2011) Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med 17:1228–1230

    Article  CAS  PubMed  Google Scholar 

  72. Hall KT, Loscalzo J, Kaptchuk TJ (2015) Genetics and the placebo effect: the placebome. Trends Mol Med 21:285–294

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Van Laarhoven AIM, Vogelaar ML, Wilder-Smith OH, Van Riel PLCM, Van De Kerkhof PCM, Kraaimaat FW et al (2011) Induction of nocebo and placebo effects on itch and pain by verbal suggestions. Pain 152:1486–1494

    Article  PubMed  Google Scholar 

  74. Benedetti F, Amanzio M, Vighetti S, Asteggiano G (2006) The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci 26:12014–12022

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Varelmann D, Pancaro C, Cappiello EC, Camann WR (2010) Nocebo-induced hyperalgesia during local anesthetic injection. Anesth Analg 110:868–870

    Article  CAS  PubMed  Google Scholar 

  76. Weihrauch TR, Gauler TC (1999) Placebo-efficacy and adverse effects in controlled clinical trials. Arzneimittelforschung 49:385–393

    CAS  PubMed  Google Scholar 

  77. Miller FG, Wendler D, Swartzman LC (2005) Deception in research on the placebo effect. PLoS Med 2(9):e262

    Article  PubMed  PubMed Central  Google Scholar 

  78. Burke W, Brown Trinidad S, Press NA (2014) Essential elements of personalized medicine. Urol Oncol 32(2):193–197

    Article  PubMed  Google Scholar 

  79. Hazin R, Brothers KB, Malin BA, Koenig BA, Sanderson SC, Rothstein MA et al (2013) Ethical, legal, and social implications of incorporating genomic information into electronic health records. Genet Med 15:810–816

    Article  PubMed  PubMed Central  Google Scholar 

  80. Kaptchuk TJ (2002) The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance? Ann Intern Med 136:817–825

    Article  PubMed  Google Scholar 

  81. Carlino E, Vase L (2018) Can knowledge of placebo and nocebo mechanisms help improve randomized clinical trials? Int Rev Neurobiol 138:329–357

    Article  PubMed  Google Scholar 

  82. Darragh M, Booth RJ, Consedine NS (2014) Consedine investigating the “placebo personality” outside the pain paradigm. J Psychosom Res 76:414–421

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, Frederick University, Nicosia, Cyprus

    P. Theodosis-Nobelos, A. Filotheidou & C. Triantis

Authors
  1. P. Theodosis-Nobelos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Filotheidou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Triantis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Triantis.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Theodosis-Nobelos, P., Filotheidou, A. & Triantis, C. The placebo phenomenon and the underlying mechanisms. Hormones 20, 61–71 (2021). https://doi.org/10.1007/s42000-020-00243-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42000-020-00243-5

Keywords

Search

Navigation